Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa

被引:61
|
作者
Baldini, L
Blini, M
Guffanti, A
Fossati, V
Colombi, M
La Targia, ML
Bertoni, F
Alietti, A
Neri, A
Bertoni, G
机构
[1] Univ Milan, Osped Maggiore, IRCCS, Ist Sci Med,Serv Ematol,Ctr Marcora,Pad Granelli, I-20122 Milan, Italy
[2] Univ Milan, Osped L Sacco, Clin Oculist, Milan, Italy
[3] Osped Fatebenefratelli & Oftalm, Div Med 1, Milan, Italy
[4] Ist Nazl Tumori, Dipartimento Radioterapia, I-20133 Milan, Italy
关键词
chemotherapy; extranodal lymphoma; MALT lymphomas; ocular adnexal lymphomas; radiotherapy; survival;
D O I
10.1023/A:1008327301372
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this study was to assess clinicopathological characteristics and outcome in a series of primary ocular adnexal lymphomas (POALs). Patients and methods: Nineteen patients with localised (stage IE) POAL were followed for a median of 96 months (24-156). The diagnosis was based on surgical biopsies followed by immunohistochemistry in 16 cases or fine-needle aspiration followed by immunocytophenotypic analysis in three cases. Twelve patients were treated with local radiotherapy (RT), five with chemotherapy (CT), and two refused further therapy after apparently radical tumour removal achieved by the diagnostic excisional biopsy. Results: The histological and immunological pattern was consistent with a diagnosis of MALT-type lymphoma (11 cases), follicular center non-Hodgkin's lymphoma (three cases), a large-cell variant of Burkitt's lymphoma (one case), and large-cell transformed MALT lymphoma (one case). Low-grade lymphoma was diagnosed in the three cases which underwent fine-needle aspiration biopsy. All of the patients achieved and maintained complete remission except for those treated with surgical excision alone (two MALT conjunctival lymphoma cases): one of these relapsed locally, the other experienced the systemic spread of a transformed diffuse large-cell lymphoma and died 72 months after diagnosis. The side effects consisted of two cases of RT-related cataract after 52 and 72 months. Conclusions: Regardless of histology, prognosis was excellent when surgery plus RT was adopted, and CT seems to be a valid alternative to RT. Surgery alone may be sub-optimal.
引用
收藏
页码:779 / 781
页数:3
相关论文
共 50 条
  • [1] Radiotherapy for the treatment of primary intraocular lymphoma and orbital (ocular adnexa) lymphomas
    Pica, Alessia
    ACTA OPHTHALMOLOGICA, 2019, 97
  • [2] Lymphomas of the Orbita and Ocular Adnexa
    Soysal, Hulya Gokmen
    Akoz, Ayla
    Ardic, Fisun
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2008, 38 (01): : 69 - 73
  • [3] Prognosis of lymphomas developed in the ocular adnexa: A single-center study
    Matsumoto, Yoshiko
    Azumi, Atsushi
    Akashi, Azusa
    Sakamoto, Mari
    Nagai, Takayuki
    Nakamura, Makoto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] Lymphomas involving the eye and the ocular adnexa
    Coupland, Sarah E.
    Damato, Bertil
    CURRENT OPINION IN OPHTHALMOLOGY, 2006, 17 (06) : 523 - 531
  • [5] Extranodal marginal zone lymphoma of the ocular adnexa
    Stefanovic, Alexandra
    Lossos, Izidore S.
    BLOOD, 2009, 114 (03) : 501 - 510
  • [6] OCCURRENCE AND PROGNOSIS OF EXTRANODAL LYMPHOMAS
    FREEMAN, C
    BERG, JW
    CUTLER, SJ
    CANCER, 1972, 29 (01) : 252 - &
  • [7] Extranodal Rosai-Dorfman disease of the eye and ocular adnexa: A clinicopathologic series of 8 cases
    Garcia, Armando L.
    Monsalve, Pedro
    Wester, Sara T.
    Lee, Wendy
    Tse, David T.
    Karp, Carol L.
    Galor, Anat
    Dubovy, Sander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [8] Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa
    Coupland, SE
    Foss, HD
    Anagnostopoulos, I
    Hummel, M
    Stein, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (03) : 555 - 562
  • [9] Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma
    Magistri, Marco
    Happ, Lanie
    Ramdial, Jeremy
    Kunkalla, Kranthi
    Dubovy, Sander R.
    Chapman, Jennifer R.
    Vega, Francisco
    Dave, Sandeep
    Lossos, Izidore S.
    BLOOD, 2018, 132
  • [10] Treatment of extranodal lymphomas
    Zucca, E
    Conconi, A
    Cavalli, F
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (03) : 533 - 547